Sotalol: Use in managing life-threatening ventricular arrhythmias

S. L. Winters, L. Enright, J. S. Banas

Research output: Contribution to journalArticlepeer-review

Abstract

Sotalol, a drug with β-blocking properties that was originally introduced as an antihypertensive agent, is now available for the treatment of life- threatening ventricular arrhythmias. In a trial that enrolled over 2,000 patients, sotalol was compared with imipramine, mexiletine, pirmenol, procainamide, propafenone, and quinidine. Treatment with sotalol was associated with the lowest recurrence of ventricular tachyarrhythmias, overall cardiac mortality, all-cause mortality, and arrhythmic death. Other, smaller, studies also support its use in this setting.

Original languageEnglish
Pages (from-to)33-37
Number of pages5
JournalPrimary Cardiology
Volume20
Issue number5
StatePublished - 1994
Externally publishedYes

Fingerprint

Dive into the research topics of 'Sotalol: Use in managing life-threatening ventricular arrhythmias'. Together they form a unique fingerprint.

Cite this